Investigators Profile

Professor O.A. Itiola
B.Pharm. (OAU), M.Pharm. (OAU), Ph.D (OAU)

The Director, Centre for Drug Discovery, Development and Production (CDDDP), his a professor of pharmaceutics and pharmaceutical technology in the Faculty of Pharmacy. He is the immediate past rector of Moshood Abiola Polytechnic, Abeokuta, Nigeria. His research interests include studies on drug formulation and drug delivery systems incorporating muco-adhesive properties of polymer systems and transdermal delivery of drugs.

Professor C.P. Babalola
B.Pharm. (OAU), M.Pharm. (UL), Ph.D(UL)

A professor of Pharmacokinetics/Pharmaceutical Chemistry and Principal Investigator of the Centre for Drug Discovery, Development and Production, Faculty of Pharmacy, University of Ibadan and currently the Vice Chancellor of Chrisland University, Abeokuta, Ogun State. Her research interests are drug analysis, pharmacokinetics/pharmacodynamics (PK/PD), biopharmaceutics, clinical trials and pharmacogenetics; with special reference to antimalarial and anti-infective agents.

Professor J.O. Moody
B.Pharm. (OAU), M.Pharm. (OAU), Ph.D(OAU)

Jones Olanrewaju Moody is a Professor of Pharmacognosy in the University of Ibadan, Nigeria. Professor Moody’s expertise is in the area of phytochemistry and drug discovery from nature for the management of malaria, sickle cell disease, and inflammation-based diseases. He has been consultant to the West African Health Organisation (WAHO) for the development of traditional medicine in the West African sub-region since 2009.

Professor Grace O. Gbotosho
B.Pharm. (OAU), M.Pharm. (OAU), Ph.D(OAU)

Professor Grace Olusola Gbotosho specializes in Clinical Pharmacokinetics and Chemoterapy. Her research interest began with focus on the reversal of antimalarial drug resistance by non-antimalarial drugs using standard in vitro drug sensitivity techniques. Her research career has also expanded into the area of molecular pharmacology and molecular epidemiology, Pharmacodynamic and pharmacokinetic studies, HIV/AIDS and tuberculosis as they interact with malaria as prevalence both diseases are on the increase in Nigeria.

Dr Michael Odeniyi
B.Pharm. (UI), M.Pharm. (UI), Ph.D (UI)

Michael A. Odeniyi graduated from the University of Ibadan, Ibadan, Nigeria where he obtained his Bachelor of Pharmacy, MSc and PhD degrees. A former Sub-Dean (Undergraduate and postgraduate programmes) of the Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria.Dr. M.A. Odeniyi is a recipient of the postdoctoral fellowship to Gifu Pharmaceutical University , Gifu, Japan and also a visiting scientist to Universiti Sains Malaysia (USM).

Dr B. Samuel
B.Pharm. (UI), M.Pharm. (UI), Ph.D (UI)

Dr Babatunde Samuel is a Lecturer in Pharmaceutical Chemistry Department, University of Ibadan. His research focus is in Natural Product Research and has many years research experience in phytomedicine development. He holds a US Patent with other senior scientists on a Phytopharmaceutical product for the treatment of sickle cell disease [Niprisan]. The same product was patented in 42 countries.

Dr O. A. Adetunji
B.Pharm. (UI), M.Pharm. (UI), Ph.D (UI)

Oladapo Adetunji graduated from the University of Ibadan, Ibadan, Nigeria where he obtained his Bachelor of Pharmacy (B.Pharm), MSc (Pharmaceutics and Industrial Pharmacy) and PhD degrees. He has also completed an Industrial Pharmacy Advanced Training programme that led to the award of a postgraduate diploma in drug discovery, development, production and regulatory (Jointly by Kilimanjaro School of Pharmacy, Tanzania, Purdue University, USA and Howard University, USA)

Dr. Adetunji’s research focus includes studies on drug formulations and delivery systems incorporating mucoadhesive properties of polymer systems and transdermal delivery of drugs; and in the usefulness of various modified starches and natural polymers as excipients in various formulations. The modification of the pharmacokinetics of solid oral dosage forms towards enhancing patient compliance, including nanotechnology based drug delivery systems are part of Dr Adetunji’s interest areas. He is also involved in preformulation studies of antimalarials and antibacterials intended for fixed-dose suppository formulation, and in the development of solvents for extemporaneous preparations of paediatric formulations.

He currently teaches in the department of Pharmaceutics and Industrial Pharmacy, University of Ibadan, Ibadan, Nigeria and is also a co-investigator in the Centre for Drug Discovery, Development and Production (CDDDP) of the University of Ibadan, Nigeria. Prior to now, he has practiced in the Pharma Industry and Community Pharmacy.

Professor Joseph Fortunak
BS (Purdue, US), Ph.D (Wisconsin, US)

Joseph Fortunak is a Professor of Chemistry and Pharmaceutical Sciences at Howard University in Washington, DC. He obtained a Bachelor of Science (B.Sc) in Chemistry from Purdue University and andM.Sc and PhD with highest distinction in Organic chemistry from the University of Wisconsin-Madison. He was a postdoctoral fellow and research professor at Cambridge University, United Kingdom. Joseph Fortunak is an ardent advocate in increasing global access to medicines, especially through pharmaceutical manufacturing in Africa.

Dr (Mrs) Olayinka Adejoke Kotila
B.Pharm. (UI), M.Pharm. (UI)

Dr (Mrs.) Olayinka Adejoke Kotila is a lecturer in the department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ibadan. She graduated from the University of Ibadan as a Pharmacist in 1999, obtained her Master of Science (M.Sc) degree in Pharmaceutical Chemistry from the same institution in 2006 and is rounding up Ph.D training in the field of Pharmacogenetics/Pharmacokinetics. She successfully genotyped over five hundred Nigerians (healthy and persons living with HIV) to determine the frequency of N-acetyltransferase II (NAT2) enzyme, making it the largest sample size for any African population genotyped for the enzyme. Pharm. (Mrs.) Kotila has been a recipient of several awards among which are: MacArthur Foundation Grant, Wellcome Trust Bursary Award, Medical Education Partnership Initiative Nigeria (MEPIN) Seed Award, NIH D43 Re-entry Grant Award, Novartis Scholarship Award and TETFUND award.